https://www.selleckchem.com/pr....oducts/ly2090314.htm
001) while the nonresponder location did not (P=.17), a finding replicated in independent cohorts of 84 depressed and 35 neurotypical participants. The responder and nonresponder stimulation locations evoked different seed based networks (FDR corrected clusters, all P.03), revealing additional brain regions related to rTMS treatment outcome. These results provide evidence from a randomized controlled trial that clinical response to rTMS is related to accuracy in targeting the region within DLPFC that is negatively correlated with